Breaking News
Get 40% Off 0
👀 Reveal Warren Buffett's stock picks that are beating the S&P 500 by +174.3% Get 40% Off

Edwards Lifesciences stock dips, ending four-day rally as market declines

Published Dec 05, 2023 20:00
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Pavlo Gonchar / SOPA Images/Sipa via Reuters Connect
 
EW
-0.37%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
US500
+0.18%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
DJI
-0.16%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
MDT
-0.66%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
SYK
+0.72%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ABT
-0.31%
Add to/Remove from a Portfolio
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

NEW YORK - Edwards Lifesciences (NYSE:EW), a prominent player in the medical devices sector, saw its shares decline by 0.48% to close at $68.85 today, halting a four-day streak of gains amid a broader market downturn. The company's stock is now considerably below its June peak of $94.87.

In the same session, major indices like the S&P 500 Index and the Dow Jones Industrial Average experienced slight drops of 0.06% and 0.22%, respectively. This minor retreat in the stock market reflects a cautious approach from investors, with trading volumes lighter than usual.

Edwards Lifesciences wasn't alone in its descent; sector peers such as Abbott Laboratories (NYSE:ABT), Medtronic (NYSE:MDT) PLC, and Stryker Corp (NYSE:SYK). also faced similar downward pressures. The collective slip among these competitors underscores a challenging day for the healthcare equipment industry within the broader context of a reticent market.

InvestingPro Insights

The latest data from InvestingPro paints a detailed financial picture of Edwards Lifesciences, a key figure in the medical devices arena. Despite a recent dip in share price, the company's financial health and operational performance offer insights into its market position. Edwards Lifesciences boasts a robust market capitalization of $41.72 billion, underlining its significant presence in the sector. The company's commitment to returning value to shareholders is evident through a P/E ratio standing at 29.2, indicating investor confidence in its earnings capacity.

On the operational front, Edwards Lifesciences has demonstrated a solid revenue growth of 8.49% over the last twelve months as of Q3 2023. This acceleration is further highlighted by a quarterly revenue growth of 12.27% for Q3 2023, suggesting a positive trend in the company's sales performance. The InvestingPro Tips highlight that the management's aggressive share buyback strategy and the high return on invested capital are influential factors that could be driving this growth.

For those looking to delve deeper into Edwards Lifesciences' potential, InvestingPro offers a wealth of additional tips, including insights on the company's high return on assets, its ability to cover interest payments with cash flows, and its moderate level of debt. In total, there are 16 InvestingPro Tips available to subscribers, providing a comprehensive analysis of the company's strengths and investment potential.

As an exclusive offer, InvestingPro is currently running a special Cyber Monday sale, with discounts of up to 60% on subscriptions. To further sweeten the deal, use the coupon code sfy23 to receive an additional 10% off a 2-year InvestingPro+ subscription. This promotion is an excellent opportunity for investors to gain access to valuable insights that could inform their investment decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Edwards Lifesciences stock dips, ending four-day rally as market declines
 

Related Articles

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email